Maternal congenital heart disease and risk of child developmental vulnerability in early school age: A

Muhammad Zakir Hossin1,2, Anne Gadermann2, Edit Nagy3

  • 1Division of Clinical Epidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

Plos Medicine
|July 2, 2026
PubMed

Insights

Maternal congenital heart disease (CHD) is linked to a higher risk of developmental vulnerability in children at school entry. Enhanced monitoring for women with CHD may reduce this risk.

Area of Science:

  • Pediatric Health
  • Cardiology
  • Developmental Pediatrics

Background:

  • Maternal congenital heart disease (CHD) is known to increase risks for adverse pregnancy outcomes.
  • The long-term impact of maternal CHD on child development is not well understood.

Purpose of the Study:

  • To investigate the association between in-utero exposure to maternal CHD and child developmental vulnerability at school entry.

Main Methods:

  • A population-based cohort study of 256,629 children in British Columbia, Canada.
  • Children's developmental vulnerability was assessed using the Early Development Instrument (EDI) at kindergarten.
  • Modified Poisson regression models were used, adjusting for multiple covariates and exploring mediation by preterm birth.

Main Results:

  • Maternal CHD was associated with a 28% higher risk of developmental vulnerability (aRR 1.28).
  • Increased risks were observed across multiple developmental domains, including physical health, social competence, language, and cognitive development.
  • Severe maternal CHD showed a stronger association with developmental vulnerability (aRR 1.98) compared to mild CHD.

Conclusions:

  • Maternal CHD is associated with increased child developmental vulnerability at school entry.
  • Further research is needed to understand the underlying mechanisms.
  • Enhanced clinical monitoring and support for women with CHD are recommended to mitigate risks for their children.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...